title: Tools and Strategies for Malaria Control and Elimination: What Do We Need to Achieve a Grand Convergence in Malaria?
abstract: Progress made in malaria control during the past decade has prompted increasing global dialogue on malaria elimination and eradication. The product development pipeline for malaria has never been stronger, with promising new tools to detect, treat, and prevent malaria, including innovative diagnostics, medicines, vaccines, vector control products, and improved mechanisms for surveillance and response. There are at least 25 projects in the global malaria vaccine pipeline, as well as 47 medicines and 13 vector control products. In addition, there are several next-generation diagnostic tools and reference methods currently in development, with many expected to be introduced in the next decade. The development and adoption of these tools, bolstered by strategies that ensure rapid uptake in target populations, intensified mechanisms for information management, surveillance, and response, and continued financial and political commitment are all essential to achieving global eradication.
authors.affiliation: Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
authors.forename: Janet
authors.initials: J
authors.lastname: Hemingway
authors.affiliation: Malaria Elimination Initiative, Global Health Group, University of California, San Francisco, San Francisco, California, United States of America.
authors.forename: Rima
authors.initials: R
authors.lastname: Shretta
authors.affiliation: Medicines for Malaria Venture, Geneva, Switzerland.
authors.forename: Timothy N C
authors.initials: TN
authors.lastname: Wells
authors.affiliation: Global Good Fund and Intellectual Ventures Laboratory, Bellevue, Washington, United States of America.
authors.forename: David
authors.initials: D
authors.lastname: Bell
authors.affiliation: Department of Epidemiology of Parasitic Diseases, Malaria Research and Training Center, University of Bamako, Bamako, Mali.
authors.forename: Abdoulaye A
authors.initials: AA
authors.lastname: Djimdé
authors.affiliation: Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States of America.
authors.forename: Nicole
authors.initials: N
authors.lastname: Achee
authors.affiliation: Jiangsu Institute of Parasitic Diseases, Meiyuan, Wuxi, Jiangsu, People's Republic of China.
authors.forename: Gao
authors.initials: G
authors.lastname: Qi
mesh_terms: D000962:Antimalarials / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D062665:Epidemiological Monitoring; D006801:Humans; D007306:Insecticides; D008288:Malaria / Q000175:diagnosis / Q000517:prevention & control*; D015980:Public Health Practice
chemical_list: D000962:Antimalarials; D007306:Insecticides